Abstract
Alzheimer's disease (AD) is characterized by neuropathological and metabolic alterations that contribute to cognitive decline. Patients with AD have low expression of brain-derived neurotrophic factor (BDNF) in brain tissue. This reduction may be associated with increased cholesterol, triglycerides and insulin resistance, contributing to the progression of cognitive decline. Recent studie…